10th Proactive GCP Compliance Conference Early Bird Pricing Ends THIS WEEK
Monday January 28th, 2019
Early Bird Pricing for the 10th Proactive GCP Compliance Conference Ends THIS Friday, February 1! REGISTER TODAY and learn from the following sessions, each mapped to their relevant section of ICH E6 R2, on March 18–20 in Philadelphia.
RISK IDENTIFICATION (ICH E6 R2 5.0.1 & 5.0.2)
Identify Critical Processes and Data, and Their Associated Risks
Cheryl McCarthy, RQAP-GCP, CQA, CBA, Associate Director, R&D Quality and Compliance, BIOGEN
RISK CONTROL AND COMMUNICATION (ICH E6 R2 5.0.4 & 5.0.5)
Define Quality Tolerance Limits and Effectively Communicate These Parameters
Celeste M. Gonzalez, B.S., CVT, RQAP-GCP, CCRP, Principal Specialist, Clinical Quality Assurance, BOSTON SCIENTIFIC
RISK REVIEW AND REPORTING (ICH E6 R2 5.0.6 & 5.0.7)
Conduct Continual Review of Risk Control Measures for Needed Adjustments and Effectively Report Any Changes
Steven Whittaker, Senior Consultant, THE AVOCA GROUP
ESSENTIAL DOCUMENTATION (ICH E6 R2 8.1)
Identify the Essential Trial Documentation and How It Should Be Maintained
Michele Weitz, Senior Director, GCP Compliance Operations, CLOVIS ONCOLOGY
Download the brochure to see what you can gain from attending.
Register by this Friday, February 1, to reserve your place at a discounted rate.
Identify, control, communicate, review, report and document risk in clinical research compliant with ICH E6 R2.
For more information on available sponsorship opportunities, please contact Arthur Butler at 917-932-0429 or email@example.com.
For all other questions and comments, contact Kristen Hunter at 212-400-6241 or firstname.lastname@example.org.
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs